Abstract
The reductionist approach has dominated scientific research for several centuries and has been widely applied in the biomedical field. However, as we move into the realm of complex diseases, this approach fails to provide the insight needed to explain disease pathogenesis. Network medicine is a new paradigm that applies network science, artificial intelligence (in particular, machine learning and graph mining), and systems biology approaches to study a disease as a consequence of physical interactions within a cell. Pieces of evidence in this field show that if a gene or molecule is involved in a disease, its direct interactors might also be suspected to play some role in the same pathological process. This evidence has lead to formulating the so-called “disease module hypothesis”: genes involved in the same disease show a high propensity to interact with each other. However, the number and structure of disease modules are largely unexplored. The purpose of this study is to systematically analyze the relationship between structural proximity of disease modules and categorical similarity of diseases, by aligning human-curated disease taxonomies with disease taxonomies automatically induced from proximity relations of disease modules within the human-gene interaction network (interactome). We propose a large-scale analysis of a vast collection of diseases leveraging a novel network and taxonomy perspective. Our aim is to support clinical studies by obtaining relevant insights to improve our understanding of disease mechanisms at the molecular level.
Similar content being viewed by others
References
Cheng F, Desai RJ, Handy DE, Wang R, Schneeweiss S, Barabási A-L, Loscalzo J. Network-based approach to prediction and population-based validation of in silico drug repurposing. Nat Commun. 2018;9(1):1–12.
Menche J, Sharma A, Kitsak M, Ghiassian SD, Vidal M, Loscalzo J, Barabási A-L. Uncovering disease-disease relationships through the incomplete interactome. Science. 2015;347(6224):1257601.
Loscalzo J, Barabási A-L, Silverman EK. Network medicine: complex systems in human disease and therapeutics, vol. 1. 1st ed. Harvard University Press; 2017.
Barabási A-L, Gulbahce N, Loscalzo J. Network medicine: a network-based approach to human disease. Nat Rev Genet. 2011;12(1):56–68.
Venkatesan K, Rual J-F, Vazquez A, Stelzl U, Lemmens I, Hirozane-Kishikawa T, Hao T, Zenkner M, Xin X, Goh K-I, et al. An empirical framework for binary interactome mapping. Nat Methods. 2009;6(1):83–90.
Goh K-I, Cusick ME, Valle D, Childs B, Vidal M, Barabási A-L. The human disease network. Proc Natl Acad Sci. 2007;104(21):8685–90.
Cheng F, Kovács IA, Barabási A-L. Network-based prediction of drug combinations. Nat Commun. 2019;10(1):1–11.
Ata SK, Wu M, Fang Y, Ou-Yang L, Kwoh CK, Li X-L. Recent advances in network-based methods for disease gene prediction. arXiv preprint arXiv:2007.10848. 2020.
Mordelet F, Vert J-P. Prodige: prioritization of disease genes with multitask machine learning from positive and unlabeled examples. BMC Bioinform. 2011;12(1):389.
Zeng X, Liao Y, Liu Y, Zou Q. Prediction and validation of disease genes using hetesim scores. IEEE/ACM Trans Comput Biol Bioinform. 2016;14(3):687–95.
Agrawal M, Zitnik M, Leskovec J, et al. Large-scale analysis of disease pathways in the human interactome. In: PSB. World Scientific; 2018. p. 111–22.
Grover A, Leskovec J. node2vec: Scalable feature learning for networks. In: Proceedings of the 22nd ACM SIGKDD international conference on knowledge discovery and data mining. 2016. p. 855–64.
Madeddu L, Stilo G, Velardi P. A feature-learning-based method for the disease-gene prediction problem. Int J Data Min Bioinform. 2020;24(1):16–37.
Rhee S, Seo S, Kim S. Hybrid approach of relation network and localized graph convolutional filtering for breast cancer subtype classification. In: Proceedings of the twenty-seventh international joint conference on artificial intelligence, IJCAI-18. International Joint Conferences on Artificial Intelligence Organization; 2018. p. 3527–34.
Pushpakom S, Iorio F, Eyers PA, Escott KJ, Hopper S, Wells A, Doig A, Guilliams T, Latimer J, McNamee C, et al. Drug repurposing: progress, challenges and recommendations. Nat Rev Drug Discov. 2019;18(1):41–58.
Paul SM, Mytelka DS, Dunwiddie CT, Persinger CC, Munos BH, Lindborg SR, Schacht AL. How to improve R&D productivity: the pharmaceutical industry’s grand challenge. Nat Rev Drug Discov. 2010;9(3):203–14.
Ezzat A, Wu M, Li X-L, Kwoh C-K. Computational prediction of drug–target interactions using chemogenomic approaches: an empirical survey. Brief Bioinform. 2019;20(4):1337–57.
Lotfi Shahreza M, Ghadiri N, Mousavi SR, Varshosaz J, Green JR. A review of network-based approaches to drug repositioning. Brief Bioinform. 2018;19(5):878–92.
Zong N, Kim H, Ngo V, Harismendy O. Deep mining heterogeneous networks of biomedical linked data to predict novel drug–target associations. Bioinformatics. 2017;33(15):2337–44.
Perozzi B, Al-Rfou R, Skiena S. Deepwalk: online learning of social representations. In: Proceedings of the 20th ACM SIGKDD international conference on knowledge discovery and data mining. 2014. p. 701–10.
Luo Y, Zhao X, Zhou J, Yang J, Zhang Y, Kuang W, Peng J, Chen L, Zeng J. A network integration approach for drug-target interaction prediction and computational drug repositioning from heterogeneous information. Nat Commun. 2017;8(1):1–13.
Zitnik M, Agrawal M, Leskovec J. Modeling polypharmacy side effects with graph convolutional networks. Bioinformatics. 2018;34(13):i457–66.
Gysi DM, Valle ID, Zitnik M, Ameli A, Gan X, Varol O, Sanchez H, Baron RM, Ghiassian D, Loscalzo J, et al. Network medicine framework for identifying drug repurposing opportunities for covid-19. arXivpreprint arXiv:2004.07229. 2020.
Piñero J, Bravo À, Queralt-Rosinach N, Gutiérrez-Sacristán A, Deu-Pons J, Centeno E, García-García J, Sanz F, Furlong LI. Disgenet: a comprehensive platform integrating information on human disease-associated genes and variants. Nucleic Acids Res. 2016;45:D833.
Blohm P, Frishman G, Smialowski P, Goebels F, Wachinger B, Ruepp A, Frishman D. Negatome 2.0: a database of non-interacting proteins derived by literature mining, manual annotation and protein structure analysis. Nucleic Acids Res. 2014;42(D1):D396–400.
Sachdev K, Gupta MK. A comprehensive review of feature based methods for drug target interaction prediction. J Biomed Inform. 2019;93:103159.
Venkatesan K, Rual J-F, Vazquez A, Stelzl U, Lemmens I, Hirozane-Kishikawa T, Hao T, Zenkner M, Xin X, Goh K-I, Yildirim MA, Simonis N, Heinzmann K, Gebreab F, Sahalie JM, Cevik S, Simon C, de Smet A-S, Dann E, Vidal M. An empirical framework for binary interactome mapping. Nat Methods. 2009;6:83–90.
Stumpf MP, Thorne T, de Silva E, Stewart R, An HJ, Lappe M, Wiuf C. Estimating the size of the human interactome. Proc Natl Acad Sci. 2008;105(19):6959–64.
Luck K, Kim D-K, Lambourne L, Spirohn K, Begg BE, Bian W, Brignall R, Cafarelli T, Campos-Laborie FJ, Charloteaux B, et al. A reference map of the human binary protein interactome. Nature. 2020;580(7803):402–8.
Lin D, et al. An information-theoretic definition of similarity. ICML. 1998;98:296–304.
Piñero J, Ramírez-Anguita JM, Saüch-Pitarch J, Ronzano F, Centeno E, Sanz F, Furlong LI. The disgenet knowledge platform for disease genomics: 2019 update. Nucleic Acids Res. 2020;48(D1):D845–55.
Kibbe WA, Arze C, Felix V, Mitraka E, Bolton E, Fu G, Mungall CJ, Binder JX, Malone J, Vasant D, Parkinson H, Schriml LM. Disease ontology 2015 update: an expanded and updated database of human diseases for linking biomedical knowledge through disease data. Nucleic Acids Res. 2015;43(D1):D1071–8.
Zhou X, Lei L, Liu J, Halu A, Zhang Y, Li B, Guo Z, Liu G, Sun C, Loscalzo J, et al. A systems approach to refine disease taxonomy by integrating phenotypic and molecular networks. EBioMedicine. 2018;31:79–91.
Goh K-I, Cusick ME, Valle D, Childs B, Vidal M, Barabási A-L. The human disease network. Proc Natl Acad Sci. 2007;104(21):8685–90.
Wood LD, Parsons DW, Jones S, Lin J, Sjöblom T, Leary RJ, Shen D, Boca SM, Barber T, Ptak J, et al. The genomic landscapes of human breast and colorectal cancers. Science. 2007;318(5853):1108–13.
Chhabra S, De S. Cardiovascular autonomic neuropathy in chronic obstructive pulmonary disease. Respir Med. 2005;99(1):126–33.
Huang BL, Chandra S, Shih DQ. Skin manifestations of inflammatory bowel disease. Front Physiol. 2012;3:13.
Maron BJ, Maron MS. Hypertrophic cardiomyopathy. Lancet. 2013;381(9862):242–55.
Gupta I, Haddock L, Greenfield DS. Secondary open-angle glaucoma and serous macular detachment associated with pulmonary hypertension. Am J Ophthalmol Case Rep. 2020;20:100878.
Lewczuk N, Zdebik A, Boguslawska J, Turno-Krecicka A, Misiuk-Hojło M. Ocular manifestations of pulmonary hypertension. Surv Ophthalmol. 2019;64(5):694–9.
Tsechkovski M, Boulyjenkov V, Heuck C. A1-antitrypsin deficiency: memorandum from a who meeting> l. Bull World Health Organ. 1997;75(5):397–415.
Young RP, Hopkins RJ, Marsland B. The gut–liver–lung axis. Modulation of the innate immune response and its possible role in chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol. 2016;54(2):161–9.
Miyamoto T, Hosoba K, Itabashi T, Iwane AH, Akutsu SN, Ochiai H, Saito Y, Yamamoto T, Matsuura S. Insufficiency of ciliary cholesterol in hereditary zellweger syndrome. EMBO J. 2020;39:e103499.
Zaki MS, Heller R, Thoenes M, Nürnberg G, Stern-Schneider G, Nürnberg P, Karnati S, Swan D, Fateen E, Nagel-Wolfrum K, et al. Pex6 is expressed in photoreceptor cilia and mutated in deafblindness with enamel dysplasia and microcephaly. Hum Mutat. 2016;37(2):170–4.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this entry
Cite this entry
Velardi, P., Madeddu, L. (2021). Aim in Genomics. In: Lidströmer, N., Ashrafian, H. (eds) Artificial Intelligence in Medicine. Springer, Cham. https://doi.org/10.1007/978-3-030-58080-3_76-1
Download citation
DOI: https://doi.org/10.1007/978-3-030-58080-3_76-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-58080-3
Online ISBN: 978-3-030-58080-3
eBook Packages: Springer Reference MedicineReference Module Medicine